<a href="https://laohu8.com/S/PGEN">Precigen</a> Inc. Signs Three-Year Commercial Supply Agreement with <a href="https://laohu8.com/S/CTLT">Catalent</a> Maryland for PAPIZEMOS Production
Precigen Inc. has entered into a Commercial Supply Agreement with Catalent Maryland, Inc., effective August 13, 2025. Under this agreement, Catalent will provide services such as analytical, development, processing, validation, and product maintenance for PAPIZEMOS, a product developed by Precigen. Precigen has committed to exclusively utilizing Catalent for external, commercial fill and finish manufacturing of all its reported volumes of the product each year within the specified territory. The initial term of the agreement is three years, with automatic one-year extensions unless terminated by either party with appropriate notice. The agreement includes provisions for pricing adjustments, maintenance fees, and termination conditions due to material breaches or other circumstances.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Precigen Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950103-25-010408), on August 18, 2025, and is solely responsible for the information contained therein.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。